Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Pharming Group N.V. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 3 | 7 | +4 |
| Shares | 192.1K | 198.5K | +6.31K (+3.3%) |
| Value | $2.46M | $2.24M | −$227.0K (−9.2%) |
New holders (4)
Institutions that held Pharming Group N.V. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 12,674 | $144.0K | 0.00% |
| Cowen Prime Services LLC | 6,300 | $71.0K | 0.03% |
| Cowen Prime Advisors LLC | 6,300 | $71.0K | 0.03% |
| Tower Research Capital LLC (TRC) | 89 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Pharming Group N.V. at the end of Q1 2021 and filed for Q2 2021 without it.
None.